Venus Concept VERO Stock
Venus Concept Price Chart
Venus Concept VERO Financial and Trading Overview
Venus Concept stock price | 2.39 USD |
Previous Close | 2.39 USD |
Open | 2.31 USD |
Bid | 0 USD x 3000 |
Ask | 0 USD x 800 |
Day's Range | 2.3 - 2.52 USD |
52 Week Range | 2.06 - 11.7 USD |
Volume | 11.63K USD |
Avg. Volume | 31.37K USD |
Market Cap | 12.66M USD |
Beta (5Y Monthly) | 1.010207 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -87.67 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13 USD |
VERO Valuation Measures
Enterprise Value | 90.63M USD |
Trailing P/E | N/A |
Forward P/E | -0.9115384 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.1352071 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.968 |
Enterprise Value/EBITDA | -2.902 |
Trading Information
Venus Concept Stock Price History
Beta (5Y Monthly) | 1.010207 |
52-Week Change | -69.61% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.7 USD |
52 Week Low | 2.06 USD |
50-Day Moving Average | 2.72 USD |
200-Day Moving Average | 4.16 USD |
VERO Share Statistics
Avg. Volume (3 month) | 31.37K USD |
Avg. Daily Volume (10-Days) | 13.07K USD |
Shares Outstanding | 5.34M |
Float | 3.32M |
Short Ratio | 0.9 |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | 57.64K |
Short % of Float | 2.05% |
Short % of Shares Outstanding | 1.08% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -47.78% |
Operating Margin (ttm) | -38.019% |
Gross Margin | 66.12% |
EBITDA Margin | -33.35% |
Management Effectiveness
Return on Assets (ttm) | -17.29% |
Return on Equity (ttm) | -268.34% |
Income Statement
Revenue (ttm) | 93.62M USD |
Revenue Per Share (ttm) | 20.2 USD |
Quarterly Revenue Growth (yoy) | -22.19% |
Gross Profit (ttm) | N/A |
EBITDA | -31226000 USD |
Net Income Avi to Common (ttm) | -44738000 USD |
Diluted EPS (ttm) | -9.77 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.41M USD |
Total Cash Per Share (mrq) | 1.18 USD |
Total Debt (mrq) | 83.43M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.147 |
Book Value Per Share (mrq) | -0.164 |
Cash Flow Statement
Operating Cash Flow (ttm) | -20444000 USD |
Levered Free Cash Flow (ttm) | -11481125 USD |
Profile of Venus Concept
Country | United States |
State | ON |
City | Toronto |
Address | 235 Yorkland Boulevard |
ZIP | M2J 4Y8 |
Phone | 877-848-8430 |
Website | https://www.venusconcept.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 384 |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Q&A For Venus Concept Stock
What is a current VERO stock price?
Venus Concept VERO stock price today per share is 2.39 USD.
How to purchase Venus Concept stock?
You can buy VERO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Venus Concept?
The stock symbol or ticker of Venus Concept is VERO.
Which industry does the Venus Concept company belong to?
The Venus Concept industry is Medical Devices.
How many shares does Venus Concept have in circulation?
The max supply of Venus Concept shares is 659.57K.
What is Venus Concept Price to Earnings Ratio (PE Ratio)?
Venus Concept PE Ratio is now.
What was Venus Concept earnings per share over the trailing 12 months (TTM)?
Venus Concept EPS is -87.67 USD over the trailing 12 months.
Which sector does the Venus Concept company belong to?
The Venus Concept sector is Healthcare.
Venus Concept VERO included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
NASDAQ Global Market Composite NQGM | 1737.75 USD — |
-6
|
— — | 1724.84 USD — | 1770.8 USD — | — - | — — |
NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}